Milestone Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Name: Milestone Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Milestone Pharmaceuticals Inc
Rating: 0.97100
Author: Trendlyne DVM scores

about

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be admi...

1.45 -0.01 (-0.68%)

43.36% Fall from 52W High

1.2M

XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Milestone Pharmaceuticals Inc is on 08 Aug 2025 for the purpose of Milestone Pharmaceuticals Inc Second Quarter Earnings Results for 2025 See details